
Brand: SORANBI
Generic Name: Sorafenib
Strength: 200 mg
Form: Oral Tablets
Manufacturer: Cipla
Availability: In Stock | Ships Worldwide
Exported by: Unnati Pharmax
Product Overview
SORANBI Sorafenib Tablets 200 mg is an advanced oral targeted therapy prescribed for the treatment of primary liver cancer (hepatocellular carcinoma), advanced kidney cancer (renal cell carcinoma), and certain types of thyroid cancer. It is a globally trusted oncology medication recommended for patients when surgery or other treatments are not suitable.
SORANBI works by blocking multiple kinases responsible for tumor growth and angiogenesis (formation of new blood vessels). By interrupting these critical pathways, it slows the spread of cancer, restricts tumor progression, and improves patient outcomes.
Why Choose SORANBI Sorafenib 200 mg?
β
Clinically proven targeted therapy for liver, kidney, and thyroid cancers
β
Multi-kinase inhibitor that disrupts tumor growth and blood supply
β
Oral tablet form for easy and convenient administration
β
Widely used in global oncology treatment plans
β
Trusted by oncologists worldwide for effective cancer management
How It Works
Sorafenib in SORANBI acts as a multi-kinase inhibitor targeting RAF kinases, VEGFR, and PDGFR receptors, which are essential for tumor development and blood vessel formation. By blocking these pathways, SORANBI reduces cancer cell growth and cuts off the tumorβs blood supply, helping control disease progression.
Composition
Each tablet contains:
Sorafenib Tosylate equivalent to Sorafenib 200 mg
Dosage and Administration
Take SORANBI as directed by your oncologist
Usual dosage: 400 mg per day (two 200 mg tablets), taken in two divided doses
Swallow the tablets whole with water, preferably on an empty stomach or as prescribed
Buy SORANBI Sorafenib 200 mg Online
Looking for affordable and authentic Sorafenib tablets online? Order SORANBI 200 mg today from Unnati Pharmax, your trusted global exporter of oncology and specialty medicines. We ensure:
β
100% genuine, high-quality medicine
β
Fast and secure worldwide shipping
β
Discreet packaging for customer confidentiality
β
Competitive pricing for both bulk and retail orders
FAQs β SORANBI Sorafenib 200 mg
Q1: What cancers is SORANBI used to treat?
A1: SORANBI is indicated for liver cancer (HCC), advanced kidney cancer (RCC), and certain thyroid cancers.
Q2: How is SORANBI usually taken?
A2: The usual dosage is 200 mg twice daily, or as prescribed by your oncologist.
Q3: When can treatment results be expected?
A3: Many patients see delayed disease progression within the first few months, though response times may vary.